PubMed for id: 12521

Year	Number of Results
1994	1
1995	2
1999	2
2000	3
2001	2
2002	2
2004	2
2005	4
2006	1
2007	2
2008	1
2010	3
2011	5
2012	1
2013	3
2014	2
2015	1
2016	1
2018	3
2019	2
2020	3
2021	2
2022	1
2023	1
2024	0

1

Tetraspanin CD82 restrains phagocyte migration but supports macrophage activation.

McGowan ENS, Wong O, Jones E, Nguyen J, Wee J, Demaria MC, Deliyanti D, Johnson CJ, Hickey MJ, McConville MJ, Wilkinson-Berka JL, Wright MD, Binger KJ. McGowan ENS, et al. iScience. 2022 Jun 3;25(7):104520. doi: 10.1016/j.isci.2022.104520. eCollection 2022 Jul 15. iScience. 2022. PMID: 35754722 Free PMC article.

2

Tetraspanin CD82 regulates S1PR₁-mediated hematopoietic stem and progenitor cell mobilization.

Saito-Reis CA, Balise VD, Pascetti EM, Jiminez M, Gillette JM. Saito-Reis CA, et al. Stem Cell Reports. 2021 Oct 12;16(10):2422-2431. doi: 10.1016/j.stemcr.2021.08.009. Epub 2021 Sep 16. Stem Cell Reports. 2021. PMID: 34534447 Free PMC article.

3

KAI1(CD82) is a key molecule to control angiogenesis and switch angiogenic milieu to quiescent state.

Lee JW, Hur J, Kwon YW, Chae CW, Choi JI, Hwang I, Yun JY, Kang JA, Choi YE, Kim YH, Lee SE, Lee C, Jo DH, Seok H, Cho BS, Baek SH, Kim HS. Lee JW, et al. J Hematol Oncol. 2021 Sep 16;14(1):148. doi: 10.1186/s13045-021-01147-6. J Hematol Oncol. 2021. PMID: 34530889 Free PMC article.

4

Tetraspanin CD82 is necessary for muscle stem cell activation and supports dystrophic muscle function.

Hall A, Fontelonga T, Wright A, Bugda Gwilt K, Widrick J, Pasut A, Villa F, Miranti CK, Gibbs D, Jiang E, Meng H, Lawlor MW, Gussoni E. Hall A, et al. Skelet Muscle. 2020 Nov 27;10(1):34. doi: 10.1186/s13395-020-00252-3. Skelet Muscle. 2020. PMID: 33243288 Free PMC article.

5

The tetraspanin CD82 regulates bone marrow homing and engraftment of hematopoietic stem and progenitor cells.

Saito-Reis CA, Marjon KD, Pascetti EM, Floren M, Gillette JM. Saito-Reis CA, et al. Mol Biol Cell. 2018 Nov 26;29(24):2946-2958. doi: 10.1091/mbc.E18-05-0305. Epub 2018 Aug 22. Mol Biol Cell. 2018. PMID: 30133344 Free PMC article.

6

Global deletion of tetraspanin CD82 attenuates bone growth and enhances bone marrow adipogenesis.

Bergsma A, Ganguly SS, Dick D, Williams BO, Miranti CK. Bergsma A, et al. Bone. 2018 Aug;113:105-113. doi: 10.1016/j.bone.2018.05.020. Epub 2018 May 18. Bone. 2018. PMID: 29782939

7

Homozygous loss of mouse tetraspanin CD82 enhances integrin αIIbβ3 expression and clot retraction in platelets.

Uchtmann K, Park ER, Bergsma A, Segula J, Edick MJ, Miranti CK. Uchtmann K, et al. Exp Cell Res. 2015 Dec 10;339(2):261-9. doi: 10.1016/j.yexcr.2015.11.006. Epub 2015 Nov 10. Exp Cell Res. 2015. PMID: 26562164

8

Differential expression of the metastasis suppressor KAI1 in decidual cells and trophoblast giant cells at the feto-maternal interface.

Koo TB, Han MS, Tadashi Y, Seong WJ, Choi JY. Koo TB, et al. BMB Rep. 2013 Oct;46(10):507-12. doi: 10.5483/bmbrep.2013.46.10.223. BMB Rep. 2013. PMID: 24148772 Free PMC article.

9

Normal viability of Kai1/Cd82 deficient mice.

Risinger JI, Custer M, Feigenbaum L, Simpson RM, Hoover SB, Webster JD, Chandramouli GV, Tessarollo L, Barrett JC. Risinger JI, et al. Mol Carcinog. 2014 Aug;53(8):610-24. doi: 10.1002/mc.22009. Epub 2013 Feb 8. Mol Carcinog. 2014. PMID: 23401136 Free PMC article.

10

Characterization of an antibody that can detect the Kai1/CD82 murine metastasis suppressor.

Custer MC, Risinger JI, Hoover S, Simpson RM, Patterson T, Barrett JC. Custer MC, et al. Prostate. 2006 May 1;66(6):567-77. doi: 10.1002/pros.20386. Prostate. 2006. PMID: 16372335

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

46 results

Results by year